Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyglutamine diseases: protein cleavage and aggregation.

H Y Zoghbi1, H T Orr

  • 1Howard Hughes Medical Institute Baylor College of Medicine Houston, Texas 77030, USA. hzoghbi@bcms.tm.edu

Current Opinion in Neurobiology
|October 6, 1999
PubMed
Summary

Nuclear aggregates in polyglutamine disorders may not cause disease but instead sequester the toxic protein. This finding challenges the traditional view of aggregate pathogenesis in neurodegeneration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The clinical and genetic spectrum of spinocerebellar ataxia 14.

Neurology·2005
Same author

Mutations in exon 1 of MECP2 are a rare cause of Rett syndrome.

Journal of medical genetics·2005
Same author

Spinocerebellar ataxia type 10 is rare in populations other than Mexicans.

Neurology·2002
Same author

Hereditary ataxia. An unfolded protein.

Lancet (London, England)·2002
Same author

Reduction of Purkinje cell pathology in SCA1 transgenic mice by p53 deletion.

Neurobiology of disease·2001
Same author

Mutations in the gene encoding methyl-CpG-binding protein 2 cause Rett syndrome.

Brain & development·2001

Area of Science:

  • Neurobiology
  • Molecular Biology
  • Genetics

Background:

  • Polyglutamine disorders are a class of neurodegenerative diseases.
  • Neuronal nuclear aggregates of disease-causing proteins are a hallmark of these conditions.
  • Previously, these aggregates were thought to be the primary cause of disease pathology.

Purpose of the Study:

  • To investigate the role of nuclear aggregates in the pathogenesis of polyglutamine disorders.
  • To determine if nuclear aggregates are the direct cause of neuronal dysfunction or if they play a protective role.

Main Methods:

  • Analysis of protein aggregation in neuronal models.
  • Assessment of cellular toxicity in the presence and absence of nuclear aggregates.
  • Investigating the interaction between aggregates and the disease-causing protein.

Related Experiment Videos

Main Results:

  • Evidence suggests that nuclear aggregates may not be the direct cause of polyglutamine disorders.
  • Findings indicate that aggregates might function to sequester the pathogenic protein, potentially reducing its toxicity.
  • This sequestration mechanism could represent a cellular defense response.

Conclusions:

  • The role of nuclear aggregates in polyglutamine disorders needs re-evaluation.
  • Aggregates may serve a protective function by sequestering toxic proteins, rather than being the primary drivers of neurodegeneration.
  • Future research should explore therapeutic strategies targeting this sequestration mechanism.